Neoprobe gains regulatory clarity on colorectal cancer detection drug

Cancer diagnostics company Neoprobe (NYSE Amex:NEOP) said it had gained clarity around the chemistry and manufacturing of its investigational colorectal cancer detection drug after a meeting with European regulators.Most significantly to Neoprobe, the meeting confirmed the company’s opportunity to develop a humanized antibody rather than a mouse-based antibody in its clinical development of RIGScan, a [...]

[Read more of this report]


Heart test company CardiOx closes $8M series C round

Heart test-maker CardiOx has closed an $8 million series C round of investment that the company plans to use to begin U.S. and European commercialization.The round was led by Michigan-based Lifeline Ventures, a new investor in Columbus, Ohio-based CardiOx, and included contributions from existing investors Early Stage Partners, Glengary and Reservoir Partners, CardiOx CEO Larry [...]

[Read more of this report]


Health data startup pushes west with new customer win

A Columbus, Ohio-based healthcare data management startup is expanding its geographic boundaries, having recently inked a deal with an eight-hospital New Mexico health system.Health Care DataWorks‘s multi-year deal with Presbyterian Healthcare Services represents the farthest west that the emerging health IT company has pushed in its quest to acquire new customers. Presbyterian is the fifth-largest [...]

[Read more of this report]


Health IT startup helps hospitals get the most out of their data

It seems incongruous that Herb Smaltz refers to Health Care DataWorks as “a young company with a long history.”While the Columbus, Ohio emerging health IT startup has been around less than three years, its healthcare data warehousing technology stretches back a decade farther than that.The former chief information officer with Ohio State University Medical Center [...]

[Read more of this report]


Cell culture firm Nanofiber Solutions eyes $1.5M investment, partnerships

A medical laboratory equipment company whose technology is used to test cancer drugs is hoping to land an investment of up to $1.5 million and a strategic partnership with a bigger company.A partnership deal would help Nanofiber Solutions to get its cell-culture technology into the hands of more researchers and drug developers.Columbus, Ohio-based Nanofiber Solutions [...]

[Read more of this report]


Ohio State gets $1.4M federal grant for wound treatment research

Ohio State University scientists have received a $1.4 million federal grant to study the use of a substance extracted from seaweed and giant kelp to treat burn wounds suffered by soldiers.The two-year grant from the Department of Defense will fund a study into the use of brown algae extracted from seaweed and giant kelp to [...]

[Read more of this report]


Male incontinence device being developed by Ohio startup

An Ohio startup thinks its male urinary incontinence device could be a big improvement over adult diapers for people who suffer from the condition.Columbus-based Continental Dry Works‘ male urinary incontinence product, called The Pocket, resembles an athletic cup and could easily be removed from the pants and discarded. The new innovative medical device features a [...]

[Read more of this report]


New medical device for urinary catheter problems getting overhaul

A urological catheter that features a camera and a light to guide implantation is planning the second-generation version of its medical device.However, it’ll likely be a year or two before Columbus, Ohio-based PercuVision rolls out version 2.0 of its DirectVision System, which is designed to address urinary catheter problems and improve the Foley catheter procedure.“What [...]

[Read more of this report]


Ohio State medical school taps Yale professor as new dean

The Ohio State University College of Medicine has picked a former chair of Yale University’s department of obstetrics as its new dean.The appointment of Dr. Charles Lockwood would be effective Sept. 1, and is subject to approval from the university’s board of trustees, according to a statement from the university.A professor at Yale, Lockwood also [...]

[Read more of this report]


Neoprobe expects FDA decision on Lymphoseek in mid-2012

Neoprobe (NYSE Amex: NEOP) remains on track to file a New Drug Application for its drug used for cancer detection, Lymphoseek, sometime in the third quarter.Factoring in the customary 10-month review period by the U.S. Food and Drug Administration, that would make a decision on the application for the drug used in cancer treatments [...]

[Read more of this report]


« Newer PostsOlder Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics